235 related articles for article (PubMed ID: 11013310)
1. Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice.
Maugeais C; Tietge UJ; Tsukamoto K; Glick JM; Rader DJ
J Lipid Res; 2000 Oct; 41(10):1673-9. PubMed ID: 11013310
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
[TBL] [Abstract][Full Text] [Related]
3. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.
Tietge UJ; Bakillah A; Maugeais C; Tsukamoto K; Hussain M; Rader DJ
J Lipid Res; 1999 Nov; 40(11):2134-9. PubMed ID: 10553017
[TBL] [Abstract][Full Text] [Related]
4. Normal production rate of apolipoprotein B in LDL receptor-deficient mice.
Millar JS; Maugeais C; Fuki IV; Rader DJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):989-94. PubMed ID: 12067909
[TBL] [Abstract][Full Text] [Related]
5. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
Tsukamoto K; Maugeais C; Glick JM; Rader DJ
J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409
[TBL] [Abstract][Full Text] [Related]
6. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
7. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
[TBL] [Abstract][Full Text] [Related]
8. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
[TBL] [Abstract][Full Text] [Related]
10. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
Jong MC; Dahlmans VE; Hofker MH; Havekes LM
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
[TBL] [Abstract][Full Text] [Related]
11. Post-secretory acquisition of apolipoprotein E by nascent rat hepatic very-low-density lipoproteins in the absence of cholesteryl ester transfer.
Dolphin PJ; Forsyth SJ; Krul ES
Biochim Biophys Acta; 1986 Jan; 875(1):21-30. PubMed ID: 3940534
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
Post SM; Groenendijk M; Solaas K; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):768-74. PubMed ID: 14962946
[TBL] [Abstract][Full Text] [Related]
13. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
Evans AJ; Sawyez CG; Wolfe BM; Connelly PW; Maguire GF; Huff MW
J Lipid Res; 1993 May; 34(5):703-17. PubMed ID: 8509711
[TBL] [Abstract][Full Text] [Related]
14. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins.
Li X; Catalina F; Grundy SM; Patel S
J Lipid Res; 1996 Jan; 37(1):210-20. PubMed ID: 8820116
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis.
Rensen PC; Jong MC; van Vark LC; van der Boom H; Hendriks WL; van Berkel TJ; Biessen EA; Havekes LM
J Biol Chem; 2000 Mar; 275(12):8564-71. PubMed ID: 10722695
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
VerHague MA; Cheng D; Weinberg RB; Shelness GS
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
[TBL] [Abstract][Full Text] [Related]
17. ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.
Hinsdale ME; Sullivan PM; Mezdour H; Maeda N
J Lipid Res; 2002 Sep; 43(9):1520-8. PubMed ID: 12235184
[TBL] [Abstract][Full Text] [Related]
18. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
Westerterp M; de Haan W; Berbée JF; Havekes LM; Rensen PC
J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms.
Srivastava RA
Mol Cell Biochem; 1996 Feb; 155(2):153-62. PubMed ID: 8700160
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]